EX-23.1 3 ex23-1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated April 4, 2024, relating to the financial statements of Galmed Pharmaceuticals Ltd. (“the Company”), appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023.

 

/s/ Brightman Almagor Zohar & Co.  

Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

Tel-Aviv, Israel

January 7, 2025